Clinical Trial Update: Sotatercept in Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial update for Sotatercept in pulmonary arterial hypertension shows the study is currently recruiting. Sponsor is the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: University of Alberta | Conditions: Pulmonary Artery Hypertension | Phase 4 | Status: RECRUITING